{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:18:15Z","timestamp":1730870295820,"version":"3.28.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"DOI":"10.7759\/cureus.73022","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T07:10:26Z","timestamp":1730790626000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analytical Study of Intravitreal Triamcinolone Acetonide Versus Bevacizumab in Managing Diabetic Macular Edema: Insights From a Tertiary Eye Care Facility in India"],"prefix":"10.7759","author":[{"given":"Harikrishnan","family":"Marappan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"A. M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajamohan","family":"M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diabetes in AmericaNIH Publ., No 95 - 1468, U.S Govt. Printing Office","author":"National Diabetes Data Group","year":"1995","unstructured":"National Diabetes Data Group. Diabetes in America, 2nd edition.  National Diabetes Data Group, Washington (DC); 1995. https:\/\/www.niddk.nih.gov\/about-niddk\/strategic-plans-reports\/diabetes-in-america-2nd-edition."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(96)01215-6","article-title":"Vascular complications in long-term South Indian NIDDM of over 25 years' duration","volume":"31","author":"Mohan V","year":"1996","unstructured":"Mohan V, Vijayaprabha R, Rema M. Vascular complications in long-term South Indian NIDDM of over 25 years' duration. Diabetes Res Clin Pract. 1996, 31:133. 10.1016\/0168-8227(96)01215-6","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein R","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984, 102:520-6. 10.1001\/archopht.1984.01040030398010","journal-title":"Arch Ophthalmol"},{"key":"ref4","article-title":"Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group","volume":"103","year":"1985","unstructured":"Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1985, 103.1796-806.","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(13)38011-7","article-title":"Early photocoagulation for diabetic retinopathy","volume":"98","year":"1991","unstructured":"Early photocoagulation for diabetic retinopathy. Ophthalmology. 1991, 98.766-85. 10.1016\/S0161-6420(13)38011-7","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)75196-7","article-title":"Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide","volume":"90","author":"Tano Y","year":"19801","unstructured":"Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 19801, 90:810-6. 10.1016\/S0002-9394(14)75196-7","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":"Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema","volume":"26","author":"Haritoglou C","year":"2006","unstructured":"Haritoglou C, Kook D, Neubauer A, et al.. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina. 2006, 26:999-1005. 10.1097\/01.iae.0000247165.38655.bf","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.129122","article-title":"Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)","volume":"92","author":"Paccola L","year":"2008","unstructured":"Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol. 2008, 92:76-80. 10.1136\/bjo.2007.129122","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/112067210801800614","article-title":"Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema","volume":"18","author":"Faghihi H","year":"2008","unstructured":"Faghihi H, Roohipoor R, Mohammadi SF, et al.. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. Eur J Ophthalmol. 2008, 18:941-8. 10.1177\/112067210801800614","journal-title":"Eur J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318176de48","article-title":"Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema","volume":"28","author":"Kook D","year":"2008","unstructured":"Kook D, Wolf A, Kreutzer T, et al.. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina. 2008, 28:1053-60. 10.1097\/IAE.0b013e318176de48","journal-title":"Retina"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas JB","year":"2003","unstructured":"Jonas JB, Kreissig I, S\u00f6fker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmology. 2003, 121:61. 10.1001\/archopht.121.1.57","journal-title":"Arch Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3341\/jkos.2009.50.8.1190","article-title":"Comparison of effects of intravitreal triamcinolone and bevacizumab in the treatment of diabetic macular edema","volume":"50","author":"Oh SB","year":"2009","unstructured":"Oh SB, Moon JW, Kim HC. Comparison of effects of intravitreal triamcinolone and bevacizumab in the treatment of diabetic macular edema. J Korean Ophthalmol. 2009, 50:1190-6. 10.3341\/jkos.2009.50.8.1190","journal-title":"J Korean Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin P","year":"2004","unstructured":"Massin P, Audren F, Haouchine B, et al.. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology. 2004, 111:218-24; discussion 224-5. 10.1016\/j.ophtha.2003.05.037","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis A","year":"2002","unstructured":"Martidis A,Duker JS, Greenberg PB. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002, 109:920-7. 10.1016\/S0161-6420(02)00975-2","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.8.972","article-title":"Pseudo-endophthalmitis after intravitreal injection of triamcinolone","volume":"87","author":"Sutter FK","year":"2003","unstructured":"Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol. 2003, 87:972-4. 10.1136\/bjo.87.8.972","journal-title":"Br J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313049-comparative-analytical-study-of-intravitreal-triamcinolone-acetonide-versus-bevacizumab-in-managing-diabetic-macular-edema-insights-from-a-tertiary-eye-care-facility-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T07:10:28Z","timestamp":1730790628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313049-comparative-analytical-study-of-intravitreal-triamcinolone-acetonide-versus-bevacizumab-in-managing-diabetic-macular-edema-insights-from-a-tertiary-eye-care-facility-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.73022","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}